These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11137571)

  • 61. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway.
    Furuke K; Shiraishi M; Mostowski HS; Bloom ET
    J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene transfer of Fas ligand induces tumor regression in vivo.
    Arai H; Gordon D; Nabel EG; Nabel GJ
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13862-7. PubMed ID: 9391118
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium.
    Hamann KJ; Dorscheid DR; Ko FD; Conforti AE; Sperling AI; Rabe KF; White SR
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):537-42. PubMed ID: 9761749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of Fas antigen (Fas, CD95)-mediated apoptosis of bovine granulosa cells by serum and growth factors.
    Quirk SM; Harman RM; Cowan RG
    Biol Reprod; 2000 Nov; 63(5):1278-84. PubMed ID: 11058530
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
    Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
    J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fas engagement increases expression of interleukin-6 in human glioma cells.
    Choi C; Gillespie GY; Van Wagoner NJ; Benveniste EN
    J Neurooncol; 2002 Jan; 56(1):13-9. PubMed ID: 11949822
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
    Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
    J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
    Odoux C; Albers A; Amoscato AA; Lotze MT; Wong MK
    Int J Cancer; 2002 Feb; 97(4):458-65. PubMed ID: 11802207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
    Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.
    Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS
    J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
    Kalas W; Matuszyk J; Ziolo E; Strzadala L
    Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
    Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
    Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of shenmai and aminophylline on apoptosis of small airway smooth muscle cells and the expression of relevant genes in rats with emphysema.
    Niu R; Liu H; Fu J
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):310-2. PubMed ID: 12674766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system.
    Caricchio R; Kovalenko D; Kaufmann WK; Cohen PL
    Clin Immunol; 1999 Oct; 93(1):65-74. PubMed ID: 10497012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
    Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Upregulation of the expression of Fas antigen and Fas ligand in a human submandibular gland ductal cell line by okadaic acid.
    Morimoto Y; Morimoto H; Okamura H; Nomiyama K; Nakamuta N; Kobayashi S; Kito S; Ohba T; Haneji T
    Arch Oral Biol; 2000 Aug; 45(8):657-66. PubMed ID: 10869477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.